AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

doi:10.1186/1750-9378-4-S2-O5

Infectious Agents and Cancer

Volume 4
Suppl 2

Viewing options:

Abstract
Full text
PDF (171KB)

Related literature:

Articles citing this article
on Google Scholar
Other articles by authors
on Google Scholar

Nguyen HQ
Okuku F
Ssewankambo F
Magaret AS
Johnston C
Wald A
Kambugu A
Corey L
Orem J
Casper C

on PubMed

Nguyen HQ
Okuku F
Ssewankambo F
Magaret AS
Johnston C
Wald A
Kambugu A
Corey L
Orem J
Casper C
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research .

Oral presentation

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

HQ Nguyen¹, F Okuku⁶, F Ssewankambo⁷, AS Magaret²^,3^,4, C Johnston¹^,5, A Wald¹^,2^,3, A Kambugu⁷, L Corey²^,3^,5, J Orem⁶ and C Casper¹^,3^,5

¹Department of Epidemiology, University of Washington; Seattle, Washington, USA

²Department of Laboratory Medicine, University of Washington; Seattle, Washington, USA

³Deparment of Medicine, University of Washington; Seattle, Washington, USA

⁴Program in Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

⁵Program in Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, Washington; USA

⁶Uganda Cancer Institute, Kampala, Uganda

⁷Infectious Disease Institute, Kampala, Uganda

corresponding author email

from 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research
Bethesda, MD, USA. 6–7 October 2008

Infectious Agents and Cancer 2009, 4(Suppl 2):O5doi:10.1186/1750-9378-4-S2-O5


Published:	17 June 2009

First paragraph (this article has no abstract)

Highly active antiretroviral therapy (HAART) alone or in combination with systemic chemotherapy has been shown to be effective therapy for AIDS-associated Kaposi sarcoma (KS) in resource-rich countries. It is not known whether HAART or chemotherapy regimens available in resource-poor regions are effective in areas where KS is hyperendemic and typically more aggressive. Therefore, we conducted a retrospective cohort study to evaluate clinical response among patients with AIDS-associated KS treated with HAART alone or in combination with chemotherapy in Uganda.